DigestRedComo funciona
Red
/
Empresas
Ra
No verificado

Ray Therapeutics

Sobre qué escribimos

BiotecnologíaIndustriaMedicina - VariosÓpticaSalud

7 Comunicados de prensa

Ver todos los comunicados de prensa
29/04/2026
Industria
Ciencia
Higiene alimentaria
Biotecnología
Medicina - Varios
Farmacéutica
Salud
Óptica
Ray Therapeutics Granted Priority Medicines (PRIME) Designation from the European Medicines Agency for RTx-015 in Retinitis Pigmentosa
Fuente
Ray Therapeutics
Editor
Business Wire
1.00
0
21/04/2026
Industria
Biotecnología
Salud
Farmacéutica
Óptica
Medicina - Varios
Ray Therapeutics Announces Upsized and Oversubscribed $125 Million Series B Financing for Vision Restoration Treatments
Fuente
Ray Therapeutics
Editor
Business Wire
1.00
0
01/04/2026
Industria
Biotecnología
Higiene alimentaria
Sanidad
Salud
Óptica
Ciencia
Medicina - Varios
Ray Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RTx-015 in Retinitis Pigmentosa
Fuente
Ray Therapeutics
Editor
Business Wire
1.00
0
17/02/2026
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Mercado laboral
Ray Therapeutics Appoints Michael Murtagh as Chief Regulatory Officer
Fuente
Ray Therapeutics
Editor
Business Wire
1.00
0
08/01/2026
Mercado laboral
Biotecnología
Óptica
Salud
Medicina - Varios
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors
Fuente
Ray Therapeutics
Editor
Business Wire
1.00
0
24/04/2025
Mercado laboral
Industria
Ciencia
Biotecnología
Medicina - Varios
Biología
Farmacéutica
Salud
Óptica
Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa
Fuente
Ray Therapeutics
Editor
Business Wire
1.00
0
16/09/2024
Ray Therapeutics Appoints Christopher Whitmore as Chief Financial Officer
Fuente
Ray Therapeutics
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0